Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Objective Assessment of Disparity Vergence After Treatment of Symptomatic Convergence Insufficiency (CI) in Children

NCT03248336 is registered in ClinicalTrials.gov with Salus University as lead sponsor.

NCT NCT03248336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03248336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Objective Assessment of Disparity Vergence After Treatment of Symptomatic Convergence Insufficiency (CI) in Children
Lead sponsor
Salus University
Phase
Not applicable
Overall status
Unknown status
Start date
September 2, 2018
Completion date
December 1, 2022
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

convergence insufficiency